Microneedle-mediated multifunctional nano-transdermal therapy system for in situ synergistic treatment of melanoma

Weiqiang Han,Lan Yu,Fengyu Liu,Qi Zhang,Hongjuan Li,Yongqian Xu,Shiguo Sun
DOI: https://doi.org/10.1016/j.colsurfa.2024.135838
IF: 5.518
2024-11-28
Colloids and Surfaces A Physicochemical and Engineering Aspects
Abstract:Traditional drug delivery methods and treatments often lack efficacy in eradicating melanoma and can cause significant toxicity to healthy tissues. Combining microneedle (MN)-based transdermal drug delivery (TDD) with in situ synergistic therapy is crucial for overcoming these challenges. Thus, a novel multifunctional nano-TDD system was developed by integrating polyvinyl alcohol (PVA) MN with hyaluronic acid (HA)-functionalized calcium peroxide/copper peroxide @ zeolitic imidazolate framework (CaO 2 /CuO 2 @ZIF-8) nanocapsule co-loaded with 1-methyltryptophan (1-MT) and disulfiram (DSF). Nanomedicines reach deeper skin layers via MNs and targeted to the melanoma site by HA. Subsequently, ZIF-8 protective layer releases 1-MT and DSF in response to the acidic tumor microenvironment. The exposed CaO 2 /CuO 2 nanoparticles decompose into Cu 2+ , Ca 2+ and hydrogen peroxide (H 2 O 2 ). Cu 2+ catalyzes the generation of hydroxyl radical (•OH) from H 2 O 2 to turn on chemodynamic therapy (CDT), and the efficiency of •OH generation can be further enhanced by depleting glutathione (GSH). Benefiting from the in-situ chelation reaction of DSF with Cu 2+ , CuET chemotherapy drugs with strong toxicity are generated. In addition, the produced Cu + can further enhance the efficacy of CDT. The massive influx of Ca 2+ exacerbates the damage to mitochondria. Ultimately, combining 1-MT to reverse the tumor's immunosuppressive microenvironment with chemotherapy and CDT-induced immunogenic cell death offers a promising and safe strategy for melanoma treatment.
chemistry, physical
What problem does this paper attempt to address?